Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer
Eugena Chang, Sarah Slater, James M. Cleary, Lestat R. Ali et al.
Journal
Cancer Cell
Topics
Immunotherapy and Immune Responses
article
Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer
Eugena Chang, Sarah Slater, James M. Cleary, Lestat R. Ali, Brandon M. Huffman, Ritchell van Dams, Chong Zuo, Jiao Shen, George Molina, Rakeeb Kureshi, Victoire Cardot‐Ruffino, Mark Fairweather, Jason L. Hornick, Thomas E. Clancy, Joshua Remland, S. Jennifer Wang, Courtney T.S. Kureshi, Kimberly J. Perez, James M. Dougan, Jonathan A. Nowak, Joseph D. Mancias, Miranda Broz, Michael Dougan, Brian M. Wolpin, Douglas A. Rubinson, Patrick J. Lenehan, Dennis A. Agardy, Jiping Wang, Harshabad Singh, Lauren Brais, Lei Zhao, Stephanie K. Dougan, Ruslan Novosiadly, Qiang Li, Katharine Barrientos, Michael J.K. Walsh
article en
Abstract
No abstract available for this paper.
Publication Tag
Cancer Cell
Institutions
Brigham and Women's Hospital (US), Bristol-Myers Squibb (United States) (US), Dana-Farber Cancer Institute (US), Dana-Farber/Harvard Cancer Center (US), Brookline Public Schools (US)
Funders
Hale Family Center for Pancreatic Cancer Research, Foundation for the National Institutes of Health, Pancreatic Cancer Action Network, Bristol-Myers Squibb, Break Through Cancer, Sky Foundation, Deutsche Forschungsgemeinschaft, Ludwig Center at Harvard